ARCHIVES

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

This article is from The Cancer Letter archive.

Vol. 29 No. 41 | November 7, 2003

Download PDF Visit The Full Archive

Related Articles

Four New Program Announcements For BRMP Trials Issued

October 22, 1982

No Issue Next Week

August 22, 1980

National Coalition Dinner Honors Cancer Program Founders, Advocates, And Cancer Survivors

March 6, 1992

Judge Rules First Amendment Protects Distribution Of Off-Label Use Information

August 14, 1998

Columnist, Kushner, Four Others Names To NCAB

May 9, 1980

Flat Centers Budget Irks House Subcommittee; Porter Repeats Call For Funding Bypass Budget

March 23, 1990